Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-09-15

Clinical Trial Update: Cholate Clearance in Fontan and Heart Failure

View source ↗

Summary

A HepQuant-sponsored clinical trial is currently recruiting to study cholate clearance in patients with Fontan physiology and right heart failure.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: HepQuant, LLC | Conditions: Fontan, Right Heart Failure | Status: RECRUITING